A Single-center Experience Comparing First- Versus Second-generation Insertable Cardiac Monitors in Pediatric Patients
Journal of Innovations in Cardiac Rhythm Management · 01.06.2022 · 13 (6) · 5048-5056
DOI: 10.19102/icrm.2022.130605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innovations in Cardiac Rhythm Management, online erschienen am 20.06.2022. Verfasst von Nathan Miller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Electrophysiology Laboratory, St. Louis Children's Hospital, St. Louis, MO, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Insertable cardiac monitors (ICMs) have undergone advancements in size and functionality over the past decade, resulting in the introduction of small, easily insertable devices capable of long-term remote monitoring. We define first-generation ICMs as implantable cardiac monitoring devices that require an incision and surgical creation of a subcutaneous pocket and second-generation ICMs as devices implanted using a custom-made tool for subcutaneous insertion, respectively. The aim of this study was to understand the differences between first- and second-generation pediatric ICM implants, implant indications, and time to diagnosis. We performed a retrospective, single-center chart review of patients who underwent ICM implantation from 2009-2019, spanning a 5-year course of first-generation ICM implantations and 5-year course of second-generation ICM implantations. Demographic data, past medical history, implant indication, and time to diagnosis were obtained. A total of 208 patients were identified over the 10-year time period, including 38 (18%) who underwent implantation with a first-generation device and 170 (82%) who underwent implantation with a second-generation device. Implant indications for first-generation ICMs included syncope (71%), palpitations (16%), inherited arrhythmia syndrome (IAS) management (5%), and premature ventricular contractions/ventricular tachycardia (VT) (8%); implant indications for second-generation ICMs included syncope (48%), palpitations (19%), IAS management (40%), premature ventricular contractions/VT (11%), atrial fibrillation (2%), tachycardia (3%), and heart block (0.5%). The average time to diagnosis was 38 weeks for patients with first-generation devices and 55 weeks for those with second-generation devices. With innovations in ICM technologies, there are expanding indications for ICM implantation in pediatric patients for long-term monitoring, specifically regarding the management of IAS patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Electrophysiology Laboratory, St. Louis Children's Hospital, St. Louis, MO, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Biomedical Engineering, Washington University McKelvey School of Engineering, St. Louis, MO, USA.
Zitieren
APA
Miller, N., Roelle, L., Lorimer, D., Dalal, A. S., Orr, W. B., Van Hare, G. F., & Avari Silva, J. N. (2022). A Single-center Experience Comparing First- Versus Second-generation Insertable Cardiac Monitors in Pediatric Patients. Journal of Innovations in Cardiac Rhythm Management, 13(6), 5048-5056. https://doi.org/10.19102/icrm.2022.130605
Vancouver
Miller N, Roelle L, Lorimer D, Dalal AS, Orr WB, Van Hare GF, et al. A Single-center Experience Comparing First- Versus Second-generation Insertable Cardiac Monitors in Pediatric Patients. Journal of Innovations in Cardiac Rhythm Management. 2022;13(6):5048-5056. doi:10.19102/icrm.2022.130605
BibTeX
@article{Miller2022,
author = {Miller, Nathan and Roelle, Lisa and Lorimer, Dean and Dalal, Aarti S and Orr, William B and Van Hare, George F and Avari Silva, Jennifer N},
title = {A Single-center Experience Comparing First- Versus Second-generation Insertable Cardiac Monitors in Pediatric Patients},
journal = {Journal of Innovations in Cardiac Rhythm Management},
year = {2022},
volume = {13},
number = {6},
pages = {5048--5056},
doi = {10.19102/icrm.2022.130605}
}
EUVIMED